India Begs Novartis To Drop Patent Challenge
India's health minister is calling for Novartis AG to back down from its controversial legal battle to patent Gleevec in the country, reportedly arguing that the Swiss drug maker's challenge to...To view the full article, register now.
Already a subscriber? Click here to view full article